OptimizeRx (OPRX) executive compensation, 2026 proxy

Stephen Silvestro, Chief Executive Officer, was paid $2.7M in fiscal 2025, up 179% from $973,132 the year before.

Filed
April 30, 2026
Annual meeting
June 9, 2026
Pay year
fiscal 2025
Named executives
3
CEO total pay
$2.7M+179% vs prior year
CEO pay in equity
58%$1.6M in awards
CEO Salary
$500,000Base salary for fiscal 2025
CEO Stock Awards
$752,184Grant date fair value
CEO Option Awards
$834,310Grant date fair value
Net Income
$5,132,000For fiscal year 2025

How Silvestro was paid

$2.7M in total for fiscal 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary18%Stock awards28%Option awards31%Non-equity incentive23%All other compensation0%

Named executive officers

ExecutiveTotal
Stephen SilvestroChief Executive Officer$2,717,717
Edward StelmakhChief Financial & Strategy Officer$1,524,170
Theresa GrecoChief Commercial Officer$1,544,265

What changed and why

  • Stephen Silvestro served as interim CEO from January 1, 2025, and as CEO starting March 10, 2025.
  • $2.7MStephen Silvestro received a total compensation of $2,717,717 for fiscal 2025 compared to $973,132 in the prior year.
  • $1.6MStock and option awards for the CEO totaled $1,586,494 in fiscal 2025 under FASB ASC Topic 718.
  • $628KNon-equity incentive plan compensation for the CEO was $627,623 for performance in fiscal 2025.
  • $72.98Total shareholder return reached $72.98 based on an initial fixed investment of $100 at December 31, 2022.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.